Publicis Life Brands Resolute boosts team
July 8, 2011Medical Communications appointment, medical communications, medical communications news, publicis
London-based healthcare communications agency Publicis Life Brands Resolute has boosted its Creative and Digital division with four new appointments. They …
Ferring relocates to new UK headquarters
July 8, 2011Sales and Marketing Ferring, UK pharma
Ferring Pharmaceuticals has moved its UK operations from Slough to new facilities just outside London in West Drayton. The Swiss …
Lilly chief: German reforms jeopardise pharma innovation
July 8, 2011Research and Development, Sales and Marketing Germany, John Lechleiter, lilly, medicines pricing
German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …
Pfizer sharpens its pharma focus
July 8, 2011Sales and Marketing Pfizer, animal health, nutrition, pharma strategy
Pfizer has given its strongest signal yet that its animal health and nutrition arms do not have long to last …
Eurocom wins healthcare services account
July 7, 2011Medical Communications Eurocom, medical communications agency, medical communications news
Eurocom Healthcare Communications has been appointed to develop a strategic marketing communications programme for a UK healthcare services company. Malling …
Working Life: Sanofi’s oncology franchise director
July 7, 2011Business Services, Sales and Marketing Working Life, careers, recruitment
Sanofi’s oncology franchise director Neale Harris talks to Pharmafocus about how his field is changing and offers some advice for …
Working through the ‘ZOUD’
July 7, 2011Business Services, Research and Development, Sales and Marketing careers, management, recruitment
Most senior managers find their executive team difficult. ‘Dysfunctional’ is a favourite word. Testing dynamics, political agendas, big personalities, strong …
BMS licences potential first-in-class cancer biologic
July 7, 2011Research and Development BMS, Cancer, biologics
Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …
Former Sanofi-Pasteur MSD president joins board at Genticel
July 6, 2011Research and Development appointment, research and development
Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …
Sanofi launches Jevtana in UK
July 6, 2011Sales and Marketing Jevtana, Sanofi, prostate cancer
Sanofi has launched its promising advanced prostate cancer drug Jevtana in the UK following EMA approval in March. Jevtana (cabazitaxel) …
GSK changes the way its US sales reps are assessed
July 6, 2011Sales and Marketing GSK, pharma sales force
GlaxoSmithKline has revealed a new way of assessing its US sales representatives’ performance in a bid to make the manufacturer’s …
Sanofi to research new types of antibiotics
July 6, 2011Research and Development Antibiotics, Rib-X Pharmaceuticals, Sanofi, research and development news
Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …
Contract research news in brief
July 6, 2011Research and Development CIToxLAB, Jubilant, PupPharma, Quintiles, Toxikon, research and development news
Quintiles helps fund Alzheimer’s drug programme, Toxikon starts building a new facility, plus updates from Jubilant, CIToxLAB and PupPharma. Quintiles …
Study claims cardiovascular risk to Pfizer’s Champix
July 6, 2011Research and Development, Sales and Marketing Champix, Chantix, Pfizer, smoking cessation
Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …
Digital Pharma: Bayer tweets breach ABPI Code of Practice
July 5, 2011Medical Communications Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter, medical communications news, social media
Bayer’s use of Twitter has caused the first social media breach of the ABPI Code of Practice. Code regulator the …
Merck to close one facility, boosts another
July 5, 2011Manufacturing and Production, Research and Development Ireland, Merck & Co, pharma job cuts, pharma manufacturing news
Merck & Co continues to shake up its network of facilities, deciding to close a recently-acquired site in the USA …
Afinitor stops tumour growth in advanced breast cancer
July 5, 2011Manufacturing and Production, Research and Development Afinitor, Novartis, Votubia, advanced breast cancer
Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …
SCM Pharma appoints Adam Sims
July 5, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive …
Pfizer re-acquires Rouses Point from Akrimax
July 5, 2011Manufacturing and Production Pfizer, pharma manufacturing news
Pfizer has decided to buy back a manufacturing facility in Rouses Point, New York, from current owner Akrimax Pharmaceuticals, and …
US team make human ‘biocollagen’ in plants
July 5, 2011Manufacturing and Production collegen, cosmetic surgery, manufacturing and production news, pharma manufacturing news
A team of researchers in the USA have successfully synthesised human collagen in transgenic maize seeds, offering a potential alternative …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
